- Open Access
Inflammatory monocytes and microglia play independent roles in inflammatory ictogenesis
Journal of Neuroinflammation volume 19, Article number: 22 (2022)
The pathogenic contribution of neuroinflammation to ictogenesis and epilepsy may provide a therapeutic target for reduction of seizure burden in patients that are currently underserved by traditional anti-seizure medications. The Theiler's murine encephalomyelitis virus (TMEV) model has provided important insights into the role of inflammation in ictogenesis, but questions remain regarding the relative contribution of microglia and inflammatory monocytes in this model.
Female C57BL/6 mice were inoculated by intracranial injection of 2 × 105, 5 × 104, 1.25 × 104, or 3.125 × 103 plaque-forming units (PFU) of the Daniel’s strain of TMEV at 4–6 weeks of age. Infiltration of inflammatory monocytes, microglial activation, and cytokine production were measured at 24 h post-infection (hpi). Viral load, hippocampal injury, cognitive performance, and seizure burden were assessed at several timepoints.
The intensity of inflammatory infiltration and the extent of hippocampal injury induced during TMEV encephalitis scaled with the amount of infectious virus in the initial inoculum. Cognitive performance was preserved in mice inoculated with 1.25 × 104 PFU TMEV relative to 2 × 105 PFU TMEV, but peak viral load at 72 hpi was equivalent between the inocula. CCL2 production in the brain was attenuated by 90% and TNFα and IL6 production was absent in mice inoculated with 1.25 × 104 PFU TMEV. Acute infiltration of inflammatory monocytes was attenuated by more than 80% in mice inoculated with 1.25 × 104 PFU TMEV relative to 2 × 105 PFU TMEV but microglial activation was equivalent between groups. Seizure burden was attenuated and the threshold to kainic acid-induced seizures was higher in mice inoculated with 1.25 × 104 PFU TMEV but low-level behavioral seizures persisted and the EEG exhibited reduced but detectable abnormalities.
The size of the inflammatory monocyte response induced by TMEV scales with the amount of infectious virus in the initial inoculum, despite the development of equivalent peak infectious viral load. In contrast, the microglial response does not scale with the inoculum, as microglial hyper-ramification and increased Iba-1 expression were evident in mice inoculated with either 1.25 × 104 or 2 × 105 PFU TMEV. Inoculation conditions that drive inflammatory monocyte infiltration resulted in robust behavioral seizures and EEG abnormalities, but the low inoculum condition, associated with only microglial activation, drove a more subtle seizure and EEG phenotype.
Neuroinflammation is an emerging unifying mechanism underlying ictogenesis and the development of epilepsy in response to a diverse array of brain insults [1,2,3]. In general, neuroinflammatory responses involve both brain-resident effector populations, such as microglia  and astrocytes , and brain-infiltrating populations, such as inflammatory monocytes [6, 7] and neutrophils . Despite recent work examining the relative contribution of these different populations to the initiation and propagation of seizures in several different animal models, the specific mechanistic roles for these cells are not yet fully understood [9,10,11,12,13,14]. Two dichotomous though not mutually exclusive populations are clearly involved in ictogenesis. Brain-resident microglia are rapidly activated in response to trauma, infection, and other brain insults, releasing cytokines, chemokines, danger signals, and other inflammatory mediators. In parallel, inflammatory monocytes rapidly infiltrate the brain in response to these same pathogenic drivers. Both populations employ similar effector mechanisms and may function antagonistically or synergistically, depending upon context and spatiotemporal interactions.
Viral encephalitis is an important cause of brain injury, ictogenesis, and temporal lobe epilepsy [15, 16]. While the vast majority of seizure and epilepsy disorders are not caused by virus infection of the CNS, the acutely amplified function of microglia and inflammatory monocytes observed during viral encephalitis is instructive regarding the role of these cells under non-infectious conditions. Indeed, a unique mouse model of viral encephalitis caused by intracranial inoculation of the Daniel’s strain of Theiler’s murine encephalomyelitis virus (TMEV) is associated with acute inflammation-induced seizures and the development of late spontaneous seizures [17,18,19,20,21]. We and others have shown in this model that brain-infiltrating inflammatory monocytes, responding to the chemoattractant CCL2 produced hyperacutely by neurons, drive profound damage to CA1 pyramidal neurons in the dorsal hippocampus and contribute to the generation of seizures via the production of inflammatory cytokines such as TNFα and IL-6 [22,23,24,25,26,27]. Recently, work led by Wolfgang Löscher has shown that microglia play a fundamental role in shaping the response to TMEV infection and provide an important protective or immunoregulatory function that may control other effector populations such as inflammatory monocytes [26, 28]. Of note, however, these investigators also reported that genetic deletion of CCR2, which prevents inflammatory monocyte infiltration and preserves the hippocampus during acute TMEV encephalitis, does not prevent the development of seizures. They interpret this to mean that infiltration of inflammatory monocytes is not required for ictogenesis in the TMEV model, a finding that is at odds with the pathogenic role we and others have established for this effector population.
To probe this disparity more closely we chose to ask the question, is the inflammatory monocyte response to viral inoculation necessary for seizures and can the ictogenic role of monocytes versus microglia be separated in the TMEV model by scaling the intensity of the monocytic infiltrate? To answer this, we inoculated mice with decreasing amounts of TMEV and assessed neuroinflammatory outcomes and pathological sequelae. Of note, TMEV is used in the field under various inoculation conditions, ranging from greater than 2 × 107 PFU per mouse [26, 28] to 2 × 104 PFU per mouse or lower , while our group and others routinely inoculate with 2 × 105 PFU per mouse [22,23,24,25, 30,31,32]. In this study we found that the inflammatory monocyte response scaled with the amount of introduced virus while microglial activation did not. Moreover, we found that lower viral inoculum elicited a specific type of low-level behavioral seizures while a larger inoculum drove robust tonic–clonic type behavioral seizures. We propose that distinct viral inoculum-induced signals drive parallel activation of microglia and recruitment of inflammatory monocytes, leading to a complex interplay of these cells in ictogenesis and pathogenesis.
The Daniels (DA) strain of TMEV was used in this study. The 2nd and 3rd derivations of a 2nd generation viral stock originally derived from the 3rd generation of virus prepared by Moses Rodriguez at Mayo Clinic in 2007 were used in this work. The Rodriguez virus was derived from an original stock provided in the early 1980s by Lehrich and Arneson . This virus was derived from the 5th passage of the original DA stock generated in 1952 by Joan Daniels . Every rederived viral stock was validated on L2 cell monolayers. Quality control validation assays included replication in 4 week old B6 mice, induction of inflammatory monocyte and neutrophil infiltration at 24 hpi, and induction of VP2+ CD8 T cells at 7 dpi. Mice were inoculated by intracranial injection of 10 μL titered virus in RPMI growth media using a Hamilton syringe, as described . The standard inoculum used by our group is 200,000 PFU per mouse. In this study, we employed fourfold serial dilutions of virus and 4 initial inocula: 200,000 PFU, 50,000 PFU, 12,500 PFU, and 3125 PFU per mouse.
C57BL/6 and LysM:eGFP (both H-2b haplotype) mice were maintained in-house, as described . Mice were group housed in the Mayo Clinic research vivarium under conventional (non-barrier) conditions with ad libitum access to food and water. Females were used for all reported experiments. All animal experiments conformed to the National Institutes of Health guidelines and were approved by the Mayo Clinic Institutional Animal Care and Use Committee (Animal Welfare Assurance number A3291-01).
Plaque assay for viral load
Mice were terminally anesthetized with isoflurane and then perfused with 30 mL PBS prior to removal of the brain and tissue weight determination. Following addition of 10 volumes (g:mL) cold DMEM, the tissue was dissociated by two 30-s bursts of a submerged rotor–stator homogenizer tip, on ice. The homogenate was clarified by centrifugation at 1000g for 20 min at 4 °C and stored in aliquots at − 80 °C. To establish viral titer, confluent monolayers of L2 fibroblasts (ATCC: CCL-149) grown in DMEM containing 10% FBS and 10 mM HEPES were washed once with serum-free DMEM and then adsorbed with tenfold serial dilutions of brain homogenate for 1 h at 37 °C, with gentle rocking every 10 min to distribute the media. At the conclusion of adsorption the cells were overlaid with 1 mL of 1% SeaPlaque agarose prepared in DMEM containing 2% FBS and 10 mM HEPES. After solidification at RT for 5–10 min the plates were incubated for 72 h at 37 °C, followed by fixation for 1 h in EtOH:HOAc:formaldehyde (6:2:1). The agarose plug was carefully extracted from the well, the fixed cell layer was washed with water, and the monolayer was stained with 1% crystal violet prepared in 20% EtOH for 5 min. After washing in water and air drying, the plaques were counted in triplicate at readable dilutions and the number was used to calculate PFU/g tissue.
Brain-infiltrating leukocyte (BILs) isolation
BILs were isolated using two different methods. For both methods mice were terminally anesthetized with isoflurane and then perfused with 30 mL PBS prior to removal of the brain. In the first method, we followed our standard published procedure with slight modification . The brain was homogenized in 5-mL ice-cold PBS by 10 strokes in a cold glass Tenbroeck homogenizer and brought to 10 mL final volume with PBS. A 30-mL round-bottom tube was prepared with 9 mL Percoll (GE Healthcare), 1 mL 10 × PBS, and 10 mL 1 × PBS at room temperature (RT). The 10 mL homogenate was added to this tube and mixed by inversion 3 times to yield a final 30% isotonic Percoll solution which was centrifuged at 7800g for 30 min at RT. The thick myelin-enriched debris layer at the top of the gradient was aspirated and the remaining homogenate solution was poured through a 40-μm filter into a 50-mL conical. The volume was brought to 50 mL with PBS and centrifuged at 800g for 5 min at RT. The pellet was resuspended in 1 mL PBS at RT, transferred to a glass round-bottom tube, underlaid with 1 mL 1.100 g/mL Percoll solution at RT, and centrifuged at 800g for 20 min at RT with no brake. The cells in the boundary layer were collected and washed in PBS prior to downstream processing.
In the second method, we used a modified enzymatic digestion protocol that is enriched in microglia and monocytes . The brain was washed 3 times with 5 mL ice-cold low glucose DMEM containing 1% penicillin–streptomycin, then placed in a 60-mm Petri dish on ice containing 5 mL of the wash solution. The hemispheres were divided and the meninges removed with a fine forceps prior to chopping the brain into ~ 1 mm2 cubes with a scalpel blade. The pieces were digested in papain and DNase I diluted in the 5 mL wash solution for 30 min at 37 °C, followed by trituration with a P1000 pipette tip. The suspension was poured through a 100-μm filter into a 50-mL conical and pieces retained by the filter were broken up by grinding with the plunger of a 3-mL syringe while continuously adding wash solution until the final volume through the filter is 15 mL. The suspension was centrifuged at 500g for 5 min at 4 °C and the pellet was resuspended in 8 mL 30% Percoll prepared in DMEM, then underlaid with 70% Percoll prepared in HBSS. The gradient was centrifuged at 650g for 25 min at RT with slow acceleration and no brake. The debris layer at the top of the gradient was aspirated and approximately 3 mL of the cloudy 30:70 gradient interface was collected, diluted with 9 mL HBSS, and spun at 500 g for 5 min. The pellet was resuspended in DMEM for downstream processing.
Flow cytometric cellular analyses
BILs were blocked in PBS containing 1% BSA and 25% (v:v) supernatant from the 2.4G2 hybridoma (anti-CD16/32; DMEM containing 5% horse serum and 5% FBS) for 30 min at 4 °C, then incubated for 30 min at 4 °C with fluorescently conjugated primary antibodies diluted 1:200 in block. After 3 washes cells were analyzed by flow cytometry using an Accuri C6 instrument (BD Biosciences). Data were post-processed in FlowJo 10.1 and re-presented using Photoshop CC 2017 and Illustrator CC 2017 (Adobe). The following primary antibodies were used, all from BD Biosciences: anti-CD45 = clone 30-F11 (#557235); anti-CD11b = clone M1/70 (#553312); anti-Ly6C/G = clone RB6-8C5 (#553129; Gr1); anti-Ly6G = clone 1A8 (#551467). Data in Fig. 1 are shown ungated. Data in Fig. 5 are derived from an initial CD45+ gate. Gates for inflammatory monocytes, neutrophils, and activated microglia are based on our published findings [24, 25] (Additional file 1: Fig. S1). Inflammatory monocytes are operationally defined as CD45hiCD11b++Gr1+1A8−; microglia are defined as CD45midCD11b+Gr1−1A8− [24, 25].
Mice were terminally anesthetized with isoflurane and then perfused via intracardiac puncture with 30 mL PBS. Hippocampi were microdissected, weighed, and disrupted in 500 μL PBS containing a protease inhibitor cocktail (10 μg/mL aprotinin, 1 μg/mL leupeptin, 1 mM phenylmethylsulfonyl fluoride, 1 mM NaF, 1 mM Na3VO4) using 10 strokes in a cold 2-mL glass Tenbroeck homogenizer. Following centrifugation at 14,000g for 10 min at 4 °C the clarified supernatants were stored at − 20 °C until use. Levels of CCL2, TNFα, and IL6 were measured using a mouse inflammatory cytokine cytometric bead array multiplex panel (#552364, BD Biosciences). Standard curves were included in all assays and samples were quantified using an Accuri C6 flow cytometer. Files were analyzed automatically using FCAP Array 3.0 (BD Biosciences) and manually using FlowJo 10.1, Microsoft Excel, and MATLAB R2017a (MathWorks).
Histology, immunostaining, and microscopy
Mice were terminally anesthetized with isoflurane and then perfused via intracardiac puncture with 30 mL PBS prior to perfusion with 50 mL of ice-cold, freshly prepared 4% paraformaldehyde (PFA). For paraffin processed tissue (Fig. 2), the brain was post-fixed for 24 h in PFA at 4 °C prior to macrosectioning the tissue with coronal cuts at the level of the optic chiasm and the infundibulum . The 3 tissue blocks were embedded together in paraffin, cut at 5 μm, mounted on charged slides, rehydrated, and stained with hematoxylin and eosin, as described . Loss of hippocampal neurons was quantified as previously described, with slight modification . In brief, damage to the stratum pyramidale of each hemisphere was scored on coded slides by two blinded observers on a scale of 0–10, with 0 representing no injury and 10 representing complete loss of the pyramidal cell layer; if 20% of neurons were lost, a score of 2 was assigned. The scores from both hemispheres were summed and the average score between the two observers was taken as the score for the individual animal. The maximum injury score in any animal is 20.
For immunofluorescence analysis (Fig. 5), the brain was post-fixed in 4% PFA overnight at 4 °C, transferred to 30% sucrose, and infiltrated overnight. The entire brain was embedded in OCT (Tissue-Tek), frozen in cryostat molds using liquid nitrogen and isopentane, then stored at − 80 °C until use. Molds were equilibrated to the cryostat temperature (− 20 °C) for 20 min, then cut at 15 μm. Sections were adhered to gelatin-coated slides at RT, briefly warmed on a hot plate to increase adhesion and flattening, and stored at − 20 °C until use. Sections on slides were rehydrated for 10 min with PBS, then blocked in PBS containing 0.5% TX-100 and 2% normal donkey serum for 1 h at RT. Sections were incubated overnight at 4 °C in 0.17 μg/mL rabbit anti-Iba1 (#019-19741, Wako Chemical) primary antibody diluted in block. Following 3 washes in PBS the sections were incubated in 6.25 μg/mL Alexa Fluor 488-conjugated donkey anti-rabbit secondary (#711-545-152, Jackson ImmunoResearch Laboratories) diluted in block for 1 h at RT. After washing in PBS, sections were mounted with VECTASHIELD antifade mounting medium containing DAPI (Vector Laboratories). Images were collected using optical sectioning and structured illumination on a Zeiss Apotome.2 microscope equipped with an Axiocam 503 camera. The following parameters were employed: Alexa 488 channel: EX (493, 450–490), EM (517, 500–550), 700 ms exposure, 1.15 μm optical section, 7 slices); DAPI channel: EX (353, 335–383), EM (465, 420–470), 10 ms exposure, 1.03 μm optical section, 7 slices. Data were processed in Zen Blue (Zeiss) and post-processed in ImageJ (National Institutes of Health) and Photoshop CC 2017. Optical stacks were combined using a maximum projection algorithm. Individual data channels were histogram leveled before recombination using identical parameters for all experimental samples. No other manipulations were performed other than resizing and cropping for orientation.
Spatial memory was assessed using a non-aversive Barnes-style platform maze  modified for mice . A platform 92 cm in diameter with 20 evenly spaced holes distributed around the outer edge was placed on top of a second platform with one escape hole, permitting 360° rotation of the escape location relative to visual cues. Four spatial cues presented as white shapes on a black background were evenly distributed around the testing platform, just outside of the maze surface. Extraneous cues were suppressed by a black encircling curtain, thorough washing of the maze surface and escape chamber between animals, and by consistency in investigator behavior. The maze was brightly and evenly illuminated with an overhead ring light. Video was captured and analyzed using the EthoVision XT 10 system (Noldus). Following acclimatization to the testing room, mice were placed in the center of the maze and allowed 5 min to find the escape hole. Mice that failed to find the hole by 5 min were gently guided to the escape. After entering the escape chamber mice were given 1 min before removal and return to the home cage. Each animal experienced 3 trials, separated by 30 min, every day for 4 days, during which the escape location was static relative to the visual cues. The latency-to-escape (s) and the number of primary errors (investigation of a non-escape hole prior to discovery of the correct escape location) were determined for each trial . On the 5th day the bottom platform was rotated 180° relative to the top platform and the visual cues, placing the escape hole in the quadrant opposite to the training location. Three probe trials, separated by 30 min, were performed to assess short-term reference memory retention. The mean probe trial latency was divided by the mean escape latency on the 4th regular trial day to generate a probe trial index. Mice that do not establish spatial reference memory exhibit an index of 1; larger indices are indicative of more time spent investigating the trained location of the escape hole prior to reverting to exploration to find the new escape location [40, 41].
Bone marrow transplantation
Starting one week prior to bone marrow reconstitution and continuing for 2 weeks after, mice were provided acidified water (pH 2.5–3.0) and irradiated chow. Starting 5 days prior to tail vein injection mice were handled daily for 5 min and inserted into a restraint device without manipulation in order to reduce the stress response. On the day of reconstitution mice were irradiated with 400 rads of whole body radiation delivered over 10 min in a J.L. Shepherd & Associates Mark 1–25, 5000 Ci 137Cs irradiator. Three hours later mice received another 400 rads over 10 min. Donor mice were killed by isoflurane overdose and decapitation. Bone marrow was flushed from both femurs and tibias using ice-cold PBS, passed once through a 32-gauge needle, gravity filtered through a 30-µm strainer, washed in PBS, resuspended in ACK buffer (155 mM NH4Cl, 10 mM KHCO3, 0.01 mM EDTA in water) to lyse red blood cells, washed in RPMI containing 10% heat-inactivated FBS, and counted by trypan blue exclusion. Three hours after the second radiation dose recipient mice were briefly warmed under a heat lamp, immobilized, and the tail was swabbed with 70% EtOH. Mice received 107 bone marrow cells via a 25-gauge needle inserted 2–4 mm into the tail vein lumen with the bevel facing upwards. Reconstitution proceeded for 4 weeks prior to experimental use.
Behavioral seizures were quantified using a modified Racine scoring system , as we have previously published . In brief, 5 cage mates were placed in an observation box for 1 h each day at 9 AM and 3 PM. An expert observer, blind to experimental condition, scored seizure manifestations using the following scale: 0 = normal behavior; 1 = freezing, orofacial twitching, repetitive orofacial grooming; 2 = repetitive head nodding or head twitching; 3 = unilateral forelimb clonus; 4 = rearing, bilateral forelimb clonus; 5 = falling, whole body tonic–clonic seizure activity. During the observation period, the maximal score during any 1-min window was recorded. Total daily seizure burden was calculated for each animal by summing the behavioral scores measured during the hour-long epochs. Total average daily seizure burden for each group was calculated by summing the seizure burdens for each animal on each day and dividing by the number of animals observed.
Kainic acid-induced seizure threshold analysis
Kainic acid (Tocris #0222) was prepared at 5 mg/mL in basic water (1 drop 10 N NaOH per mL water). For each separate experiment (comparing uninfected and the 2 inoculation groups) adequate kainic acid stock was prepared for all animals . On the day of testing, kainic acid was diluted to 1 mg/mL in PBS. Mice were weighed and marked on the tail with a black marker for identification. Individual syringes were prepared for each animal and each dose. Mice were placed in cohorts of 5 in an open top disposable cage with bedding under normal room lighting. At time zero mice received 5 mg/kg kainic acid by intraperitoneal injection (~ 30 s per mouse). A trained observer carefully observed the animals throughout the course of the experiment and rated behavioral seizures as described above. Subsequent kainic acid injections were delivered at 30, 60, 90, 120, and 150 min. All behavioral events were recorded for time of onset. Mice were removed from the experiment and euthanized after the initiation of the second independent episode of Racine 4/5 seizures and the time and number of doses were recorded. All mice fulfilled status epilepticus criteria after 6 or fewer doses of kainic acid.
Mice were instrumented at 4–5 weeks of age following our established methods with minor modifications . Briefly, animals were administered buprenorphine sustained release and then anesthetized with isoflurane in an induction chamber. After placement on the stereotactic rig and evidence of a surgical plane of anesthesia, an incision was made in the scalp to expose bregma and the midline suture. Screw electrodes wrapped with silver wire were screwed into burr holes placed at the following coordinates relative to bregma: channel 1: − 2.0 caudal, + 1.7 lateral; channel 2: − 2.0 caudal, − 1.7 lateral; reference: + 1.0 caudal, + 1.5 lateral; ground: ~ − 5.0 caudal, − 0.5 lateral. Head mounts (Pinnacle #8235-SM) were soldered to the wires connected to the screw electrodes. Dental cement was used to adhere the headmount and protect the recording electrodes. Following 1–2 weeks post-operative recovery mice were connected to a tethered Pinnacle Technologies pre-amplifier and data acquisition and conditioning system. Data were sampled at 1000 Hz either during 1-h epochs at the same time of day or continuously for several days. Following baseline collection, mice were inoculated with TMEV and recorded again at 72 hpi. Data were converted to European data format (.edf) and analyzed in Matlab using standard line length and power spectrum calculations.
Experimental design and statistical analyses
All figures were created in Photoshop and Illustrator. Statistics are reported following Curran-Everett guidelines . Data were analyzed and graphed in JMP Pro 14.1 or GraphPad Prism 9.0 with α = 0.05 established a priori. All bar graphs show the mean and all error bars represent 95% confidence intervals (CI). Where relevant, each symbol represents one animal. Flow plots in Figs. 1 and 4 are representative of at least 5 mice in a minimum of two separate experiments. Histology in Fig. 2 is representative of at least 3 mice per group in two separate experiments. Immunostaining in Figs. 3 and 4 is representative of at least 3 mice in two separate experiments. For all quantitative analyses the number of mice are indicated in the statistics provided in the figure legends. Data were analyzed by one-way or two-way ANOVA as appropriate to the experimental design using a linear least-squares fit. Normality was assessed by Shapiro–Wilk test. Tukey’s multiple comparison was used for parametric data. Dunn's non-parametric pairwise comparison was used for all one-way ANOVA tests on data that were not from the normal distribution. For two-way ANOVA tests on non-parametric data, the data were stabilized using a Box–Cox power transformation  prior to application of the Tukey HSD (honestly significant difference) pairwise comparison test. For non-parametric data that included zeros, the values were first recast as the reciprocal log10 of the value plus one before the power transformation. For non-parametric data that could not be transformed, Dunnett’s least-squares mean analysis versus control was employed for pairwise comparisons. Comparisons of cumulative distribution frequencies used the Kolmogorov–Smirnov test. All analyses were subjected to post hoc power analysis on the noncentral F distribution using β = 0.2 and experiments were only reported if sufficient power was attained (π ≥ 0.8). Cohen's standardized effect size ds is also reported for experiments to establish the magnitude of the statistical claim . Line length comparisons were performed using a nested one-way ANOVA with multiple comparisons corrected using the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli to yield the false discovery rate (q-value) .
The size of the inflammatory monocyte response to acute TMEV infection scales with the size of the inoculum
LysM:eGFP reporter mice were intracranially inoculated with 200,000 PFU, 50,000 PFU, 12,500 PFU, or 3125 PFU of TMEV in 10 μL (fourfold dilution series). Mice were killed at 24 hpi and BILs were prepared using our standard method . Cells were immunolabeled for CD45 and analyzed by flow cytometry (Fig. 1). As we previously described , inoculation with 200,000 PFU TMEV induced robust infiltration of CD45hi cells that were readily detectable by forward and side scatter profile (Fig. 1A, 1F). This inoculum was also marked by a large population of infiltrating inflammatory monocytes, defined by a GFPmid profile (Additional file 1: Fig. S1), and by a smaller population of infiltrating neutrophils, defined by a GFPhi profile (Fig. 1K, P, Q). Inoculation with fourfold less virus (50,000 PFU) still resulted in a clear population of CD45hi infiltrating cells (Fig. 1B, G) and a sizable inflammatory monocyte population (Fig. 1L, P, Q). Inoculation with 16-fold less virus (12,500 PFU) also still induced infiltration, with a forward-side scatter profile that was very similar to 50,000 PFU (Fig. 1C) and clearly detectable CD45hi (Fig. 1H) and GFP+ populations (Fig. 1M, P, Q. Finally, inoculation with 64-fold less virus (3,125 PFU) resulted in only a low level of CD45hi infiltrating cells (Fig. 1D, I) and very few GFP+ cells (Fig. 1N, P, Q), though the amount was still higher than occurs in sham-inoculated mice (Fig. 1E, J, O–Q) . We conclude that the relative size of the inflammatory monocyte response induced by TMEV inoculation scales with the amount of infectious virus in the inoculum but that even two logs less virus is sufficient to induce measurable inflammatory infiltration.
The amount of hippocampal injury induced by acute TMEV infection scales with the size of the inoculum
As we have previously reported, inoculation of B6 mice with 200,000 PFU TMEV results in profound neural injury largely restricted to the CA1 layer of the dorsal hippocampus [24, 25] (Fig. 2A, E, I, O). At 7 dpi, this injury typically results in loss of more than 50% of CA1 pyramidal neurons in both hemispheres and clear evidence of ongoing tissue injury and infiltration between the hippocampal fissure and the white matter tract overlying the hippocampus. Even in areas of relative preservation, the CA1 layer is marked by a plethora of dead or dying cells in mice inoculated with 200,000 PFU TMEV (Fig. 2I). To quantify this neural injury, the percentage of CA1 exhibiting clear pyramidal neuron loss at low magnification at approximately level 285 in the Allen brain atlas (e.g., Fig. 2A) is converted to a number between 0 and 10 (100% injury to the layer in one hemisphere = 10) and the hemispheric values are summed. As shown in Fig. 2O, 10 out of 10 mice exhibited scores of 9 or greater at 7 dpi following inoculation with 200,000 PFU TMEV. Fourfold reduction in the viral inoculum resulted in a general reduction in CA1 injury (Fig. 2B, F, O) and 16-fold less virus resulted in clear preservation of CA1 neurons (Fig. 2C, G, J), with 8 out of 8 mice exhibiting total scores less than 5 and 3 of 8 mice exhibiting no CA1 cell loss (Fig. 2O). Of note, CA1 neurons were preserved in mice inoculated with 12,500 PFU TMEV despite evidence of infiltrating cells within the pyramidal layer (arrowheads, Fig. 2J) and above the hippocampal fissure (arrowheads, Fig. 2G) at 7 dpi (predominantly lymphocytes), reflective of a productive anti-viral response [49, 50]. Further reduction of the viral inoculum to 3125 PFU per mouse resulted in essentially no hippocampal injury (Fig. 2D, H, O). Finally, the general pattern of injury was maintained through 45 dpi, with the two highest inoculum groups showing distortion of the hippocampal architecture (Fig. 2K, L) and the two lowest inoculum groups exhibiting maintenance of the architecture (Fig. 2M, N). We conclude that the amount of injury to the CA1 pyramidal neuron layer induced by TMEV inoculation scales with the amount of infectious virus in the inoculum. We also conclude that inoculation with 12,500 PFU TMEV results in robust preservation of CA1 and the hippocampal architecture. Based on the clear disparity between inoculation with 200,000 PFU (“normal”) and 12,500 PFU (“low”) these two conditions were used for the remainder of the study.
Cognitive performance is maintained in mice inoculated with less TMEV
We have previously reported complete loss of spatial learning ability in B6 mice inoculated with 200,000 PFU TMEV using the Morris water maze [23, 25, 31, 32]. This finding was replicated using a modified Barnes maze test (Fig. 2P, Q). In contrast to mice in the 200,000 PFU TMEV group, animals inoculated with 12,500 PFU exhibited the same improvement in latency-to-escape over a 4-day testing period as vehicle-inoculated mice (Fig. 2P). Moreover, the low inoculum group, but not the 200,000 PFU TMEV group, exhibited the same reduction in error rate observed in vehicle-inoculated mice (Fig. 2Q). These results indicate that cognitive deficits scale with the size of the initial viral inoculum and hence with the size of the inflammatory infiltrate. Notably, learning is maintained in the animals inoculated with 12,500 PFU despite the presence of a reduced but detectable inflammatory infiltrate, suggesting that the mechanisms leading to CA1 neuron loss and consequent learning impairment require a threshold number of inflammatory monocytes.
Viral load after infection is equivalent between inoculation groups, but acute inflammatory cytokine and chemokine levels are markedly different
The most parsimonious explanation for the observations above is that introduction of less virus into the brain results in less viral replication and therefore less inflammation and less injury. However, we found that the amount of infectious virus recovered from the brain at 1, 3, and 7 dpi was statistically identical between mice inoculated with 200,000 PFU TMEV and mice inoculated with 12,500 PFU TMEV (Fig. 3A). Moreover, the distribution of virus in the hippocampus at 3 dpi, as assessed by immunostaining, was identical between the inocula (Fig. 3B, C). This finding indicates that differences in viral replication and viral burden, per se, cannot explain the preservation of hippocampal neurons observed in the low inoculum group. On the other hand, while mice inoculated with 200,000 PFU TMEV produced roughly 10 ng/mouse of the inflammatory monocyte chemoattractant CCL2 in the hippocampus at 24 hpi, mice inoculated with 12,500 PFU produced less than 1 ng/mouse and only showed a small and insignificant increase relative to uninfected mice. By 3 dpi the levels of CCL2 in the hippocampus were at uninfected levels in both groups (Fig. 3D). Likewise, mice inoculated with 200,000 PFU TMEV produced 400 pg/mouse TNFα and 300 pg/mouse IL6 in the hippocampus at 24 hpi, while mice inoculated with 12,500 PFU showed no increase in these inflammatory cytokines above vehicle-inoculated controls (Fig. 3E, F). By 3 dpi the levels of hippocampal TNFα and IL6 in the high inoculum group had returned almost to control values and the low inoculum group remained at control levels. Notably, the amount of IFNγ in the hippocampus at 3 dpi was ~ 3 ng/mouse in animals inoculated with either 200,000 PFU TMEV (2826 ± 804 pg/mouse) or 12,500 PFU TMEV (3258 ± 733 pg/mouse), relative to less than 100 pg/mouse in the vehicle control group (46 ± 28 pg/mouse) (F(2,12) = 7.692, P = 0.0071 by one-way ANOVA; high vs low inoculum: P = 0.8788; high vs vehicle: P = 0.0221; low vs vehicle: P = 0.0092 by Tukey’s multiple comparison test). These findings indicate that the initial viral burden in the brain controls acute inflammatory responses associated with TNFα and IL6 production in the hippocampus and that this inflammatory program is largely resolved by 3 dpi. In contrast, the host ability to mount a robust anti-viral IFNγ response at 3 dpi is independent of the initial inoculum and is consistent with the equivalent viral load at this timepoint. These observations also support our previous findings regarding CCL2 in the recruitment of inflammatory monocytes to the hippocampus in TMEV-infected mice  and suggest that the intensity of the inflammatory monocyte infiltrate dictates the amount of TNFα or IL6 generated in the infected hippocampus at 24 hpi.
Microglial activation is equivalent between inoculation groups
To quantify differences in neuroinflammatory responses between inocula, we employed flow cytometric analysis of cells prepared using two different methods. In the first, we homogenized the brain and isolated cells over sequential Percoll gradients using our standard methodology (Fig. 4A, B, D, E, L–Q). We have shown that this preparation yields infiltrating inflammatory monocytes and neutrophils as well as resident microglia [25, 35]. In the second preparation, we used a modified enzymatic digestion and gradient method that is reportedly enriched for microglia  (Fig. 4A, C). Both preparations revealed an increase in the number of CD45+CD11b+Ly6G/Cneg microglia in response to inoculation with 200,000 PFU and 12,500 PFU TMEV, relative to vehicle inoculation (Fig. 4B, C). In the same analyses, the number of CD45+CD11b++Ly6G/C+ inflammatory monocytes was increased in mice inoculated with 200,000 PFU TMEV but was severely attenuated in mice inoculated with 12,500 PFU, consistent with the findings in Fig. 1. Further quantitative analysis revealed a significant reduction in the number of CD45hiCD11b++Ly6C/G+1A8− inflammatory monocytes in mice inoculated with 12,500 PFU TMEV relative to inoculation with 200,000 PFU TMEV (Fig. 4D) but no significant change in the number of CD45midCD11b+Ly6C/G−1A8− microglia between the groups (Fig. 4E). The equivalent microglial response was also revealed by increased Iba-1 immunoreactivity and the presence of hyper-ramified Iba-1+ cells in mice inoculated with either 200,000 PFU (Fig. 4H) or 12,500 PFU (Fig. 4I) relative to control mice (Fig. 4G). This finding was replicated in LysGFP reporter mice, with animals inoculated with 200,000 PFU showing microglial activation (increased Iba1+) and GFP+ infiltrate (Fig. 4J), while mice inoculated with 12,500 PFU showed equivalent microglia activation but no GFP+ cells (Fig. 4K).
The specific identification of microglia by flow cytometry within the context of infiltrating inflammatory monocytes remains a contentious matter. We have previously characterized microglia as CD45midCD11b+Ly6C/G−1A8− and inflammatory monocytes as CD45hiCD11b++Ly6C/G+1A8−. In order to verify these parameters and facilitate flow cytometric analysis of microglial activation markers, we employed bone marrow chimeric mice in which irradiated B6 hosts were reconstituted with LysGFP bone marrow (B6:LysGFP) or irradiated LysGFP hosts were reconstituted with B6 bone marrow (LysGFP:B6) (Fig. 4L–N). We verified that the CD45+GFP+ infiltrating cells isolated from the brain at 24 hpi following inoculation with 200,000 PFU TMEV were clearly separable from the CD45+GFP− microglia by relative expression of Ly6C/G (Fig. 4M). We also verified the converse, that CD45+Ly6C/Ghi/mid infiltrating cells were clearly separable form CD45+Ly6C/Glo/neg microglia by the relative expression of GFP in B6 mice reconstituted with LysGFP bone marrow (Fig. 4N). Using these parameters, we further verified that all CD45mid cells were GFP− and Ly6C/Glo/neg cells were TMEM119+ microglia while all GFP+Ly6C/Ghi cells were TMEM119− (Fig. 5O). These findings validate the use of CD45midLy6C/Glo/neg gating to separate microglia from infiltrating cells. Comparison of CD44 expression on CD45midLy6C/Glo/neg microglia at 24 hpi revealed that this marker, along with CD86, but not CD11c, was increased to the same extent in animals inoculated with either 200,000 PFU or 12,500 PFU TMEV (Fig. 4P). Quantitative analysis confirmed that microglia upregulated CD44 and CD86 activation markers to the same extent in response to either inocula (Fig. 4Q), indicating that in contrast to the inflammatory monocyte response, local activation of microglia is either insensitive to the inoculum-scaling factors that drive CCL2 production and/or is directly responsive to the amount of replicating virus in the brain rather than the initial amount of virus introduced into the brain.
Microglial activation is sufficient to induce low-level Racine seizures and alter seizure threshold, but inflammatory monocyte infiltration is necessary to drive high-level seizures
We have previously reported that mice inoculated with 200,000 PFU TMEV develop severe behavioral seizures within 3 days of infection . This finding was replicated in the current study, with the majority of mice in this group experiencing at least a Racine level 2 seizure each day between 3 and 8 dpi and more than half of the mice experiencing Racine 3 or higher seizures between 4 and 7 dpi (Fig. 5A). Moreover, the aggregate average seizure burden per mouse in the 200,000 PFU group reached a peak of 20 at 5 dpi (Fig. 5B). In contrast, inoculation with 12,500 PFU TMEV resulted in clear attenuation of seizure intensity, as reflected by the development of only Racine level 1 seizures in the majority of mice between 2 and 10 dpi (Fig. 5A). No animal in this group was ever observed experiencing a seizure above Racine level 2. Likewise, the aggregate average seizure burden at 5 dpi in the low inoculum group did not exceed 3 (Fig. 5B). The presence of Racine 1/2 events suggested that the low inoculum condition still resulted in electrophysiological abnormalities though not to the same extent as the high inoculation conditions. Mice were implanted with screw electrodes and EEG data were collected at baseline (prior to inoculation) and at 3 dpi. Compared to baseline EEG (Fig. 5C), both 200,000 PFU (Fig. 5D) and 12,500 PFU (Fig. 5E) inoculations resulted in dysregulated EEG, including evidence of increased power across a broad spectrum of frequencies. Given the difficulties in identifying specific ictal events in mice infected with TMEV, we compared line length in 1-s windows through a ~ 90-min recording epoch at baseline and on 3 dpi (Fig. 5F). Both 200,000 PFU and 12,500 PFU inoculations led to an increase in line lengths greater than 3 standard deviations above the mean (F(3,12) = 13.82, P = 0.0003 by one-way ANOVA across groups; 200,000 vs baseline: q < 0.0001, P = 0.0001; 12,500 vs baseline: q = 0.0035, P = 0.0133). Of note, mice inoculated with 12,500 PFU TMEV exhibited fewer EEG periods with line lengths in excess of 3SD compared to mice inoculated with 200,000 PFU (q = 0.0053, P = 0.0252). These results suggested that microglial activation in the context of strongly reduced monocyte infiltration in mice inoculated with 12,500 PFU TMEV was sufficient to induce electrophysiological dysregulation, but was not sufficient to induce high-level Racine events or increased periods of high-frequency activity in the EEG. This further suggested that microglial activation in the context of reduced monocytic infiltration would alter the threshold to seizures induced by kainic acid. To test this, mice were inoculated with 200,000 or 12,500 PFU TMEV or with vehicle and then stimulated with repeated intraperitoneal kainic acid until induction of status epilepticus (SE; defined as two independent episodes of Racine 4/5 seizures) (Fig. 5G). While control mice required 5 or 6 doses and took 160 ± 3 min to reach SE, mice inoculated with 200,000 PFU reached SE after 2 doses and 46 ± 9 min. Notably, mice inoculated with 12,500 PFU required more doses of KA (H(3) = 42.66, P < 0.0001 by Kruskal–Wallis one-way ANOVA; 200,000 vs 12,500: P = 0.0005 by Dunn’s pairwise analysis) and took longer to reach SE (95 ± 15 min; F(2,52) = 106.1, P < 0.0001 by one-way ANOVA across groups; 200,000 vs 12,500: P < 0.0001 by Tukey’s pairwise comparison). This indicates that the seizure threshold was significantly higher in mice with only microglial activation relative to mice with both microglial activation and inflammatory monocyte infiltration. However, given that the response in mice inoculated with 12,500 PFU TMEV was also different from control mice (KA doses: 12,500 vs vehicle: P = 0.0080 by Dunn’s pairwise analysis; time to SE: 12,500 vs vehicle: P < 0.0001 by Tukey’s pairwise comparison), it is clear that microglial activation was sufficient to disrupt electrophysiological homeostasis.
Infection of wild-type B6 mice with the Daniel's strain of TMEV is a unique model of ictogenesis and epilepsy associated with acute viral encephalitis [18, 20]. This model is marked by a clear dependence upon neuroinflammation as the pathophysiological driver of hippocampal injury and seizure development, with evidence from multiple labs supporting a role for infiltrating inflammatory monocytes, activated microglia, and inflammatory cytokine production in the initiation and propagation of seizures. Despite variability in inoculation parameters and nomenclature across investigators, the general consensus is that acute infection with TMEV drives CCR2-dependent CNS infiltration of inflammatory monocytes that secrete proinflammatory cytokines such as TNFα and IL6, leading to hippocampal circuit dysregulation and seizure induction. Likewise, there is consensus that microglia are robustly activated by TMEV infection and play an important role in shaping anti-viral immune responses. However, the interaction of inflammatory monocytes and microglia and the relative contribution of each cell type to both hippocampal injury and ictogenesis remains unclear.
Löscher and colleagues recently showed that genetic deletion of either CCR2 or CX3CR1 did not impact viral clearance and did not prevent the development of seizures, but did prevent hippocampal injury . However, while CCR2 knockout mice developed seizures at the same frequency as wild-type mice, the seizures were of reduced severity, leading the investigators to suggest that inflammatory monocytes exacerbate seizures and hippocampal neuropathology. Our findings support this contention and further suggest that microglial activation in response to TMEV inoculation drives a specific type of behavioral seizure that may be separable from the more severe seizures induced by inflammatory monocytes. Given the absence of TNFα and IL6 induction in mice inoculated with 12,500 PFU TMEV, our findings suggest that these cytokines, produced by infiltrating inflammatory monocytes, may generate the intense Racine level 3–5 seizures that are most readily visualized in this model. In contrast, the low-level, subtle Racine level 1–2 seizures are generated irrespective of inflammatory monocyte infiltration and may be driven by distinct microglia-mediated mechanisms. At the present time it is unknown whether there is a difference in the anatomical or cellular locus of these different seizure phenotypes and we do not know if one type is more associated with the development of epilepsy in this model.
Löscher and colleagues also showed that pharmacological depletion of microglia with PLX5622 exacerbated hippocampal injury and increased seizure progression, concomitant with an increase in IL6 production . While the authors indicate that the absolute number of presumptive inflammatory monocytes (CD45hiCD11b+ cells) was not different in infected PLX5622-treated mice vs infected controls, the data are difficult to assess based on the very high level of such cells detected in the brain in uninfected mice by these investigators. Nonetheless, their findings suggest that microglia may “put the brakes” on inflammatory monocyte-mediated inflammatory processes that contribute to ictogenesis and hippocampal damage. Our data indicate that microglial activation, as marked by hyper-ramification and increased Iba-1 immunoreactivity , occurs even in conditions in which inflammatory monocyte infiltration and concomitant high-level behavioral seizures and hippocampal injury are strongly attenuated. While Löscher has importantly pointed out that a population of microglia acquire levels of CD45 that render them indistinguishable from infiltrating monocytes, it is critical to note that our flow cytometric assessment of monocytes vs microglia uses Ly6G/C expression in CD45+ cells to segregate the populations [52, 53]. We find that inoculation with 12,500 PFU TMEV generates the same microglial response as inoculation with 200,000 PFU TMEV but results in more than 80% attenuation of inflammatory monocyte infiltration. Given that seizure burden and intensity were strongly suppressed in mice inoculated with 12,500 PFU TMEV, we conclude that inflammatory monocytes directly drive these events. It remains to be determined whether microglia produce factors that limit inflammatory monocyte cytokine production and/or suppress inflammatory or oxidative aspects of the hippocampal environment that facilitate monocyte-mediated effector functions.
An unexpected observation in this study was the similarity in viral load at 1, 3, and 7 dpi in mice inoculated with either 200,000 PFU or 12,500 PFU TMEV. This finding suggests that there may be only a limited number of infectable targets and that even 12,500 PFU is saturating for these sites. Indeed, Fujinami and colleagues recently showed that inoculation with 4,000, 400, or 40 PFU of TMEV still resulted in the same level of TMEV antigen expression in the CA2 region (CA1/CA3 border) of the hippocampus . While they did not measure infectious virions, this finding supports the contention that only a small amount of introduced virus drives the consequent viral proliferation. As we have previously pointed out, mathematical modeling suggests that only 20–2000 cells are infected by 3 hpi , and the stereotypical drop (> 100-fold) in recoverable infectious virus measured at 1 dpi (relative to the inoculum) indicates that most virus (> 99%) does not persist after inoculation (Fig. 3). In fact, recovery of approximately 2000 PFU per gram tissue at 1 dpi means that there are only about 1000 infectious plaque-forming units across the entire brain. Our previous immunohistochemistry and in situ hybridization analyses suggest that only tens of cells are infected in the hippocampus at 2 dpi  and the Fujinami finding, though the timepoint was not specified, supports this contention .
What is notable about this outcome is that only a small number of cells therefore have the capacity to respond to cytosolic viral RNA sensing mediated by receptors such as IFIH (MDA5) and DHX58 (LGP2) [55, 56]. The role for these RIG-I-like pathogen sensors is highlighted by the fact that inoculation with UV-inactivated TMEV does not drive CCL2 production and does not induce infiltration of inflammatory monocytes , indicating that TLR-mediated recognition of non-infectious viral particles does not directly contribute to monocyte recruitment. However, what is not clear is whether such TLR-mediated signaling may be involved in microglial activation following inoculation. Given the robust activation of microglia induced by 12,500 PFU TMEV, it is possible that these cells sense extracellular or endocytosed virus without the need for productive infection. In contrast, since 12,500 PFU TMEV only induced a small amount of CCL2 and since we previously showed that neurons are the primary source of CCL2 during acute infection , it is possible that productive infection and introduction of viral RNA into the neuronal cytoplasm is required for the induction of an inflammatory monocyte response. However, because inoculation with 12,500 PFU TMEV led to the same amount of infectious viral load by 24 hpi, any effect of RIG-I-like receptor signaling on monocyte recruitment must be restricted to the most acute phase of the infection. Our previous observation that CCL2 is induced in the brain at levels in excess of 4000 pg/mouse by 3 hpi supports this model . Thus, while currently speculative, the dichotomy between CCL2 production via RIG-I-like receptor-mediated pathways and microglial activation via TLR pathways may establish the set-point for consequent neuroinflammatory sequelae. If sufficient virus is introduced into the brain to drive productive infection of neurons within the first several hours, RIG-I-like receptor signaling drives CCL2 production, recruitment of inflammatory monocytes, and the creation of a TNFα- and IL6-rich environment that dysregulates hippocampal synapses and leads to severe seizures. In parallel, TLR-mediated activation of microglia drives a response that modulates inflammatory monocyte-mediated effector functions, resulting in the observation that the absence of microglia exacerbates hippocampal injury and seizure severity. On the other hand, if only enough virus is introduced to acutely drive TLR signaling that activates microglia but not neurons, the environment, while still inflammatory, per se, does not lead to inflammatory monocyte recruitment and does not progress to high-level seizures, though low-level behavioral seizures are still induced.
Welsh and colleagues recently characterized the ictogenic effect of two different variants of the Daniel’s strain of TMEV that exhibit different growth characteristics on baby hamster kidney cells . One variant grows as large plaques while the other is characterized by small plaques. In notable parallel with our current study, these investigators found that the different variants induced substantially different pathogenic and ictogenic outcomes following intracranial inoculation. While the small variant robustly replicated in the brain, the large variant did not. Likewise, the small variant drove more microglial activation than the large variant, as revealed by Iba-1 immunolabeling, and the small variant induced the type of intense CA1 hippocampal injury we describe in this study while mice inoculated with the large variant showed no such injury. Moreover, mice infected with the small variant had a larger inflammatory monocyte response and, critically, developed more severe seizures, with nearly 90% of small variant infected mice exhibiting Racine 5 seizures but less than 10% of large variant hosts showing the same. While the Welsh study did not exactly replicate our findings (for example, both microglial activation and inflammatory monocyte responses were impacted), it is interesting that the mechanism underlying the size variant difference may relate to mutations in the TMEV Leader protein and L* protein that are involved in viral evasion of host innate responses. Specifically, the large variant has mutations at sites that are expected to compromise the ability of TMEV to inhibit type I interferon responses, resulting in host suppression of productive infection . Thus, it is possible that the large variant in the Welsh study was similar to our lower inoculum-induced response, in which virions are introduced that may drive TLR signaling on microglia but which are deficient in replication efficacy necessary to drive cytosolic receptor signaling in neurons. Ultimately, it will be necessary to characterize the specific in situ cellular anti-viral signal transduction events elicited by acute TMEV inoculation in order to determine which pathways may be involved in ictogenesis. In particular, it will be valuable to determine if specific signaling events may be amenable to pharmacological manipulation that leads to a reduction in inflammatory monocyte infiltration without compromising the innate immune pathways necessary for viral control [22, 23, 31]. Limiting bystander pathology while maintaining immunological integrity may not only lead to neuroprotection in patients with viral encephalitis, but may also open up new avenues for thwarting the neuroinflammatory mechanisms of ictogenesis across the epilepsies .
Based on our findings, we conclude that the relative size of the inflammatory monocyte response induced at 24 hpi by TMEV inoculation scales with the amount of infectious virus in the initial inoculum, despite the development of equivalent infectious viral load by 24 hpi. In contrast, the microglial response to TMEV inoculation does not scale with the amount of infectious virus in the inoculum. We also conclude that CA1 pyramidal neuron injury and disruption of spatial learning scale with the initial inoculum, suggesting that these events are primarily driven by inflammatory monocyte-mediated processes. Moreover, while TMEV inoculation conditions that drive strong inflammatory monocyte infiltration result in the development of robust behavioral seizures between 3 and 8 dpi, the low inoculum condition, associated predominantly with microglial activation, drives the development of a subtle behavioral seizure phenotype that arises by 1 dpi and persists through at least 10 dpi. The differential but interdependent roles of infiltrating inflammatory monocytes and activated microglia suggest a model for acute-onset refractory status epilepticus in patients in which neuroinflammatory events alter the threshold to seizures while peripheral inflammatory mediators drive the brain over this threshold and into ictogenesis. Such a model has implications for designing new therapeutic strategies to stop refractory status epilepticus.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Analysis of variance
Theiler's murine encephalomyelitis virus
Hematoxylin and eosin
Chemokine (C–C motif) ligand 2
Tumor necrosis factor alpha
Dulbecco’s modified Eagle medium
Phosphate buffered saline
Hanks' balanced salt solution
Fetal bovine serum
4-(2-Hydroxyethyl)-1-piperazine ethanesulfonic acid
Bovine serum albumin
Broekaart DWM, Anink JJ, Baayen JC, Idema S, de Vries HE, Aronica E, Gorter JA, van Vliet EA. Activation of the innate immune system is evident throughout epileptogenesis and is associated with blood-brain barrier dysfunction and seizure progression. Epilepsia. 2018;59:1931–44.
Wang M, Chen Y. Inflammation: a network in the pathogenesis of status epilepticus. Front Mol Neurosci. 2018;11:341.
Ravizza T, Vezzani A. Pharmacological targeting of brain inflammation in epilepsy: therapeutic perspectives from experimental and clinical studies. Epilepsia Open. 2018;3:133–42.
Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21:1359–69.
Soung A, Klein RS. Viral encephalitis and neurologic diseases: focus on astrocytes. Trends Mol Med. 2018;24:950–62.
Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity. 2018;49:595–613.
Stegelmeier AA, van Vloten JP, Mould RC, Klafuric EM, Minott JA, Wootton SK, Bridle BW, Karimi K. Myeloid cells during viral infections and inflammation. Viruses. 2019;11.
Ng LG, Ostuni R, Hidalgo A. Heterogeneity of neutrophils. Nat Rev Immunol. 2019;19:255–65.
Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA, Henshall DC, Kaufer D, Koh S, Loscher W, et al. Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia. 2017;58(Suppl 3):27–38.
Varvel NH, Neher JJ, Bosch A, Wang W, Ransohoff RM, Miller RJ, Dingledine R. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proc Natl Acad Sci USA. 2016;113:E5665-5674.
Bozzi Y, Caleo M. Epilepsy, seizures, and inflammation: role of the C-C Motif ligand 2 chemokine. DNA Cell Biol. 2016;35:257–60.
Ashhurst TM, van Vreden C, Niewold P, King NJ. The plasticity of inflammatory monocyte responses to the inflamed central nervous system. Cell Immunol. 2014;291:49–57.
Eyo UB, Murugan M, Wu LJ. Microglia-neuron communication in epilepsy. Glia. 2017;65:5–18.
Patel DC, Tewari BP, Chaunsali L, Sontheimer H. Neuron-glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci. 2019;20:282–97.
Tyler KL. Acute viral encephalitis. N Engl J Med. 2018;379:557–66.
Venkatesan A, Michael BD, Probasco JC, Geocadin RG, Solomon T. Acute encephalitis in immunocompetent adults. Lancet. 2019;393:702–16.
DePaula-Silva AB, Hanak TJ, Libbey JE, Fujinami RS. Theiler’s murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: models for multiple sclerosis and epilepsy. J Neuroimmunol. 2017;308:30–42.
Gerhauser I, Hansmann F, Ciurkiewicz M, Loscher W, Beineke A. Facets of Theiler’s murine encephalomyelitis virus-induced diseases: an update. Int J Mol Sci. 2019;20:448.
Barker-Haliski ML, Loscher W, White HS, Galanopoulou AS. Neuroinflammation in epileptogenesis: insights and translational perspectives from new models of epilepsy. Epilepsia. 2017;58(Suppl 3):39–47.
Broer S, Hage E, Kaufer C, Gerhauser I, Anjum M, Li L, Baumgartner W, Schulz TF, Loscher W. Viral mouse models of multiple sclerosis and epilepsy: marked differences in neuropathogenesis following infection with two naturally occurring variants of Theiler’s virus BeAn strain. Neurobiol Dis. 2017;99:121–32.
Broer S, Kaufer C, Haist V, Li L, Gerhauser I, Anjum M, Bankstahl M, Baumgartner W, Loscher W. Brain inflammation, neurodegeneration and seizure development following picornavirus infection markedly differ among virus and mouse strains and substrains. Exp Neurol. 2016;279:57–74.
Howe CL, LaFrance-Corey RG, Goddery EN, Johnson RK, Mirchia K. Neuronal CCL2 expression drives inflammatory monocyte infiltration into the brain during acute virus infection. J Neuroinflammation. 2017;14:238.
Howe CL, LaFrance-Corey RG, Mirchia K, Sauer BM, McGovern RM, Reid JM, Buenz EJ. Neuroprotection mediated by inhibition of calpain during acute viral encephalitis. Sci Rep. 2016;6:28699.
Howe CL, Lafrance-Corey RG, Sundsbak RS, Lafrance SJ. Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain. J Neuroinflammation. 2012;9:50.
Howe CL, Lafrance-Corey RG, Sundsbak RS, Sauer BM, Lafrance SJ, Buenz EJ, Schmalstieg WF. Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infection. Sci Rep. 2012;2:545.
Kaufer C, Chhatbar C, Broer S, Waltl I, Ghita L, Gerhauser I, Kalinke U, Loscher W. Chemokine receptors CCR2 and CX3CR1 regulate viral encephalitis-induced hippocampal damage but not seizures. Proc Natl Acad Sci USA. 2018;115:E8929–38.
Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS. Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol. 2011;85:6913–22.
Waltl I, Kaufer C, Gerhauser I, Chhatbar C, Ghita L, Kalinke U, Loscher W. Microglia have a protective role in viral encephalitis-induced seizure development and hippocampal damage. Brain Behav Immun. 2018;74:186–204.
Patel DC, Wallis G, Dahle EJ, McElroy PB, Thomson KE, Tesi RJ, Szymkowski DE, West PJ, Smeal RM, Patel M, et al: Hippocampal TNFalpha signaling contributes to seizure generation in an infection-induced mouse model of limbic epilepsy. eNeuro. 2017;4.
Bijalwan M, Young CR, Tingling J, Zhou XJ, Rimmelin AR, Leibowitz JL, Welsh CJ. Characterization of plaque-sized variants of Daniel’s (DA) strain in Theiler’s virus-induced epilepsy. Sci Rep. 2019;9:3444.
Buenz EJ, Rodriguez M, Howe CL. Disrupted spatial memory is a consequence of picornavirus infection. Neurobiol Dis. 2006;24:266–73.
Buenz EJ, Sauer BM, Lafrance-Corey RG, Deb C, Denic A, German CL, Howe CL. Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection. Am J Pathol. 2009;175:668–84.
Lehrich JR, Arnason BG, Hochberg FH. Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci. 1976;29:149–60.
Daniels JB, Pappenheimer AM, Richardson S. Observations on encephalomyelitis of mice (DA strain). J Exp Med. 1952;96:517–30.
Lafrance-Corey RG, Howe CL. Isolation of brain-infiltrating leukocytes. J Vis Exp. 2011;52:2747.
Stark JC, Wallace E, Lim R, Leaw B. Characterization and isolation of mouse primary microglia by density gradient centrifugation. J Vis Exp. 2018.
Barnes CA. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol. 1979;93:74–104.
Rosenfeld CS, Ferguson SA. Barnes maze testing strategies with small and large rodent models. J Vis Exp. 2014;2014:e51194.
Harrison FE, Reiserer RS, Tomarken AJ, McDonald MP. Spatial and nonspatial escape strategies in the Barnes maze. Learn Mem. 2006;13:809–19.
Illouz T, Madar R, Clague C, Griffioen KJ, Louzoun Y, Okun E. Unbiased classification of spatial strategies in the Barnes maze. Bioinformatics. 2016;32:3314–20.
Sharma S, Rakoczy S, Brown-Borg H. Assessment of spatial memory in mice. Life Sci. 2010;87:521–36.
Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32:281–94.
Bergstrom RA, Choi JH, Manduca A, Shin HS, Worrell GA, Howe CL. Automated identification of multiple seizure-related and interictal epileptiform event types in the EEG of mice. Sci Rep. 2013;3:1483.
Umpierre AD, Bennett IV, Nebeker LD, Newell TG, Tian BB, Thomson KE, White HS, White JA, Wilcox KS. Repeated low-dose kainate administration in C57BL/6J mice produces temporal lobe epilepsy pathology but infrequent spontaneous seizures. Exp Neurol. 2016;279:116–26.
Curran-Everett D, Benos DJ. Guidelines for reporting statistics in journals published by the American Physiological Society. Am J Physiol Endocrinol Metab. 2004;287:E189-191.
Sakia RM. The Box-Cox transformation technique: a review. J R Stat Soc Ser D (Statist). 1992;41:169–78.
Cohen J. A power primer. Psychol Bull. 1992;112:155–9.
Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93:491–507.
Goddery EN, Fain CE, Lipovsky CG, Ayasoufi K, Yokanovich LT, Malo CS, Khadka RH, Tritz ZP, Jin F, Hansen MJ, Johnson AJ. Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T Cell infiltration of the brain. Front Immunol. 2021;12:726421.
Deb C, Howe CL. NKG2D contributes to efficient clearance of picornavirus from the acutely infected murine brain. J Neurovirol. 2008;14:261–6.
Morrison HW, Filosa JA. A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J Neuroinflammation. 2013;10:4.
Saiwai H, Ohkawa Y, Yamada H, Kumamaru H, Harada A, Okano H, Yokomizo T, Iwamoto Y, Okada S. The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am J Pathol. 2010;176:2352–66.
Stirling DP, Yong VW. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res. 2008;86:1944–58.
Sanchez JMS, DePaula-Silva AB, Doty DJ, Truong A, Libbey JE, Fujinami RS. Microglial cell depletion is fatal with low level picornavirus infection of the central nervous system. J Neurovirol. 2019;25:415–21.
Dias Junior AG, Sampaio NG, Rehwinkel J. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol. 2019;27:75–85.
Freundt EC, Drappier M, Michiels T. Innate immune detection of cardioviruses and viral disruption of interferon signaling. Front Microbiol. 2018;9:2448.
Ricour C, Borghese F, Sorgeloos F, Hato SV, van Kuppeveld FJ, Michiels T. Random mutagenesis defines a domain of Theiler’s virus leader protein that is essential for antagonism of nucleocytoplasmic trafficking and cytokine gene expression. J Virol. 2009;83:11223–32.
Vezzani A, Fujinami RS, White HS, Preux PM, Blumcke I, Sander JW, Loscher W. Infections, inflammation and epilepsy. Acta Neuropathol. 2016;131:211–34.
Manling Xie and Dr. Shai Kunda contributed experimental results during the early stages of this work. Hunter Olson and Ian Olson provided technical support for multiple aspects of this work.
This work was supported by the NIH (NINDS, NS064571 and NS109956, CLH). The funding agency played no role in the design, analysis, or interpretation of the study.
Ethics approval and consent to participate
All studies were conducted in accordance with the United States Public Health Service’s Policy on Humane Care and Use of Laboratory Animals and with approval from the Mayo Clinic Institutional Animal Care and Use Committee (Animal Welfare Assurance number A3291-01).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
. Gating strategy for brain-infiltrating leukocyte analyses. Singlets are further refined by GFP intensity or CD45-positivity and then sub-gated on Gr1 or 1A8 and CD11b. Cells that are GFP bright are Gr1-positive and 1A8-positive neutrophils, while cells that are GFP mid are Gr1-positive 1A8-negative inflammatory monocytes.
About this article
Cite this article
Howe, C.L., LaFrance-Corey, R.G., Overlee, B.L. et al. Inflammatory monocytes and microglia play independent roles in inflammatory ictogenesis. J Neuroinflammation 19, 22 (2022). https://doi.org/10.1186/s12974-022-02394-1
- Theiler’s murine encephalomyelitis virus
- Inflammatory monocyte
- Viral encephalitis